Associated Papers
Insights into Hyperparathyroidism-Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of CDC73 Gene and Parafibromin-Deficient Tumours.
Gheorghe AM et al.
International Journal of Molecular Sciences, 2024
Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-Mediated Hypercalcemia.
Khairi S et al.
Hormones & Cancer, 2020
Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations.
Iacobone M et al.
World Journal of Surgery, 2020
Structural Biology Helps Interpret Variants of Uncertain Significance in Genes Causing Endocrine and Metabolic Disorders.
Ittisoponpisan S et al.
Journal of the Endocrine Society, 2018
30019023 (PubMed )
Supplement: js.2018-00077.sd2.xls › Sheet1
Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion.
Muscarella LA et al.
Oncotarget, 2018
29755684 (PubMed )
Supplement: oncotarget-09-20721-s002.xlsx › Foglio1
Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
Cardoso L et al.
Human Mutation, 2017
Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.
Newey PJ et al.
Human Mutation, 2010
Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred.
Iacobone M et al.
Langenbeck's Archives of Surgery, 2009
Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism.
Masi G et al.
Endocrine-related Cancer, 2008
Select a paper to view details